Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
7.56
0.00 (0.00%)
At close: Jun 8, 2026, 4:00 PM EDT
7.63
+0.07 (0.89%)
After-hours: Jun 8, 2026, 6:54 PM EDT
Corbus Pharmaceuticals Holdings Employees
Corbus Pharmaceuticals Holdings had 36 employees as of December 31, 2025. The number of employees increased by 8 or 28.57% compared to the previous year.
Employees
36
Change (1Y)
8
Growth (1Y)
28.57%
Revenue / Employee
n/a
Profits / Employee
-$2,348,000
Market Cap
140.07M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 36 | 8 | 28.57% |
| Dec 31, 2024 | 28 | 9 | 47.37% |
| Dec 31, 2023 | 19 | -14 | -42.42% |
| Dec 31, 2022 | 33 | -8 | -19.51% |
| Dec 31, 2021 | 41 | -35 | -46.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ADC Therapeutics | 193 |
| Molecular Partners AG | 134 |
| Agenus | 81 |
| Connect Biopharma Holdings | 64 |
| Jyong Biotech | 27 |
| Genelux | 26 |
| AN2 Therapeutics | 21 |
| Canton Strategic Holdings | 12 |
CRBP News
- 4 days ago - Corbus Pharmaceuticals Holdings Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 7 days ago - Corbus Pharmaceuticals Holdings Transcript: KOL event - Transcripts
- 12 days ago - Corbus Pharmaceuticals price target lowered to $30 from $38 at Wedbush - TheFly
- 13 days ago - Corbus Pharmaceuticals share selloff overdone, says Guggenheim - TheFly
- 13 days ago - Corbus Pharmaceuticals Holdings Transcript: Study update - Transcripts
- 13 days ago - Corbus Pharmaceuticals Holdings Press release: Study update - Filings
- 13 days ago - Corbus Pharmaceuticals Holdings Slides: Study update - Filings
- 13 days ago - Corbus Pharmaceuticals reports updated CRB-701 Phase 1/2 data - TheFly